Filing excerpt
anticipated timing for United States (U.S.) Food and Drug Administration (U.S. FDA) and non-U.S. regulatory approval of new products;
sec.gov/Archives/edgar/data/1613103/000162828026011107/mdt-20260123.htmRead the full source
Medtronic10-Q: Product launch
Medtronic anticipates new product launches pending U.S. FDA and international regulatory approvals.
What happened
The company is expecting regulatory approvals for new products in the near future. These approvals will trigger go-to-market campaigns, requiring investment in sales enablement, marketing automation, and supply chain logistics to support the launches.
Source
Other signals in this filing (4)
- Goodwill impairmentMedical Surgical unit with $19.8B goodwill has only a 12% fair value cushion, signaling impairment risk.Goodwill impairment
- Acquisition announcedMedtronic confirms ongoing acquisition and investment strategy, signaling future M&A activity.Acquisition announced
- International growthCompany is focused on increasing its presence in markets outside the U.S.International growth
- DivestitureMedtronic highlights divestitures as a key strategic tool, signaling potential portfolio changes.Divestiture
Extracted by Autobound
From the Signal API record- Signal
- 10-Q: Product launch
What this signalsFilings often name leadership changes, deals and spending plans.
- Fiscal year end
- 01/23
- Filed
- Feb 24, 2026
More from Medtronic
- PatentsMedtronic, Inc. uses Fletcher Yoder P.C. as outside IP counsel.Patents
- InvestmentMedtronic Lifts Guidance as FDA Clears Robot Instrument and MiniMed Spinoff AdvancesInvestment
- EarningsMedtronic plc stock gains attention as diabetes spin-off and robotic surgery clearance reshape its oEarnings
- IntegrationWhat Does Medtronic (MDT) FDA Clearance Mean For Its Hugo Surgery Push?Integration
- 8-KMedtronic initiates spin-off of its MiniMed business unit via an exchange offer8-K
- LaunchMedtronic announces FDA clearance for LigaSure™ RAS Maryland instrument on the Hugo™ RAS systemLaunch
More 10-Q signals at other companies
- SEC 10-QMillerKnoll, Inc.Jeffrey M. Stutz appointed Interim Chief Executive Officer.SEC 10-Q
- SEC 10-QCID HoldCo, Inc.Disclosed material weaknesses in financial reporting due to insufficient accounting staff and controls.SEC 10-Q
- SEC 10-QScholastic CorporationCore school channels decline with fewer book fairs and lower club participation.SEC 10-Q
The full record
From the Signal API recordDetails
- CIK
- 1613103
- Accession number
- 0001628280-26-011107
- Filing year
- 2026
- Fiscal year
- 0
- Why it matters
- Go-to-market support
- Signal category
- Strategic
Topics and mentions
Regions named
- US
Extraction
- Confidence
- High
- Relevance
- 70%
- Sentiment
- Positive
- Detected
- Mar 3, 2026
- signal_type
sec-10q- signal_subtype
productLaunch
Use this data
Get every 10-Q signal for Medtronic and the companies you sell to, in the tools you already use.
Ask Claude about it
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Medtronic this week?”
Send it to your own tools
The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.
Try it free
Sign up and spend your free credits on the companies you sell to.
Start Free1,000 free credits
The API returns more than this page shows
This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the API
Signal
signal_nameValue in the APIassociationValue in the API
Start Free1,000 free creditsUse it in Claude via MCP
Show the full JSONHide the full JSONThe record on this page and the API request
GET /v1/signals/79f3ed93-ebdf-4d42-ab5b-7a24e182195c returns this record as JSON. POST /v1/companies/enrich returns every signal for medtronic.com.
{
"signal_id": "79f3ed93-ebdf-4d42-ab5b-7a24e182195c",
"signal_type": "sec-10q",
"signal_subtype": "productLaunch",
"detected_at": "2026-03-03T06:51:41.923+00:00",
"company": {
"name": "Medtronic",
"domain": "medtronic.com"
},
"data": {
"detail": "The company is expecting regulatory approvals for new products in the near future. These approvals will trigger go-to-market campaigns, requiring investment in sales enablement, marketing automation, and supply chain logistics to support the launches.",
"summary": "Medtronic anticipates new product launches pending U.S. FDA and international regulatory approvals.",
"excerpts": "anticipated timing for United States (U.S.) Food and Drug Administration (U.S. FDA) and non-U.S. regulatory approval of new products;",
"relevance": 0.7,
"sentiment": "positive",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/1613103/000162828026011107/mdt-20260123.htm",
"filing_date": "2026-02-24",
"filing_year": 2026,
"fiscal_year": 0,
"fiscal_year_end": "01/23",
"sales_relevance": "Go-to-market support",
"signal_category": "strategic",
"regions_mentioned": [
"US"
]
}
}
curl https://signals.autobound.ai/v1/signals/79f3ed93-ebdf-4d42-ab5b-7a24e182195c \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"medtronic.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.